Corporate Governance

Basic Approach

Santen believes that it is vital to upgrade and strengthen corporate governance systems in order to achieve and enhance corporate value, and thus returns to shareholders.

Santen has adopted a “Company with Board of Company Auditors” system as defined in Japan’s Companies Act. Santen shall continuously be working to upgrade and strengthen corporate governance by making the most of the current system.

First, the functions of the Board of Directors are to make decisions concerning the vital execution of the business as well as to monitor the execution of the business by the management and Directors. Santen will operate in a manner to maximize both of the above functions.

Santen expects its Outside Directors to be actively involved in the Board of Directors in decision making on individual managerial issues, taking advantage of their wide range of experience and knowledge. Concurrently therewith, Santen shall also ask for their opinions and recommendations from the view of strengthening the function of monitoring Santen’s management.

Furthermore, Santen established the Corporate Strategy Committee, the Nominating Committee and the Executive Compensation Committee, which are all voluntary committees made up of Inside and Outside Directors, with the aim of improving management transparency and objectivity. Moreover, Santen will go forward to strengthen management and improve the speed of business execution through the introduction of a corporate officer system.

Corporate Auditors audit the Board of Directors and executive sections by utilizing the Office of Corporate Auditor or collaborating with the Internal Auditing Group, bringing into view not only the legality but also the appropriateness and effectiveness of the performance of their duties, and Santen shall endeavor to strengthen the function of the Board of Directors and executive sections.

Basic Policy On Corporate Governance

Corporate Governance Report

Management System

In addition to various statutory functions, the Board of Directors formulates management policies, strategies, and business plans for the Santen Group. The Board of Directors makes decisions relating to the acquisition or disposal of major financial assets and important organizational or personnel-related matters, as well as oversees the conduct of business at Santen and its subsidiaries. To further strengthen the corporate governance system by improving management transparency and objectivity, Santen has established three deliberative committees comprising inside and outside directors. In addition, we have adopted a corporate officers' system to reinforce the management of, and improve the speed of business operations.

The Composition of the Board of Directors and others

Taking into account the knowledge, experience, and skills that are necessary to fulfill its roles and responsibilities, the Board is composed of the appropriate number of members in accordance with the Company Act and the articles of incorporation, ensuring overall balance and diversity.
The composition of the Board of Directors, the Board of Corporate Auditors, and the Committees is as follows:

Composition of the Board of Directors, the Board of Corporate Auditors, and the Committees (as of June 27, 2023)

◎:Chairperson of each committee

 NameBoard of DirectorsBoard of Corporate AuditorsCorporate Strategy CommitteeNominating CommitteeExecutive Compensation Committee
DirectorsAkira Kurokawa
Takeshi Ito
Kanoko Oishi
(Outside Director)
Yutaro Shintaku
(Outside Director)
Kunihito Minakawa
(Outside Director)
Noboru Kotani
(Outside Director)
Tamie Minami
(Outside Director)
Corporate AuditorsHiroshi Isaka
(Standing Corporate Auditor)
Masahiko Ikaga
(Outside Corporate Auditor)
Junichi Asatani
(Outside Corporate Auditor)
Yaeko Hodaka
(Outside Corporate Auditor)
Number of meetings
(April, 2022 - March, 2023)

Skill Matrix of Directors and Corporate Auditors (as of June 27, 2023)

Santen believes that, upon nomination of its candidates for Director and Corporate Auditor, it is important to establish its effective governance system towards the sustainable enhancement of its corporate value through both of the following: (i) in the meetings of the Board of Directors, Directors and Corporate Auditors that attend are engaged in multifaceted deliberations on the appropriateness of business strategies, risks upon realization thereof and other aspects, and also they appropriately supervise the status of execution thereof; and (ii) the Board of Corporate Auditors conducts the audit from the perspective of not only legality but also appropriateness and effectiveness of the Board of Directors and other executive divisions, and thereby fully exerts its function.
Meanwhile, based on the long-term vision “Santen 2030” and the New Medium-Term Management Plan, Santen endeavors to solve social issues through vision to maximize our people and patient-value contribution in the prescription pharmaceutical business. Also, in these efforts, Santen will exercise leadership globally allowing us to contribute to people around the world based on ophthalmologic medical needs which differ depending on countries and areas.
Santen considers that, in addition to planning and carrying out corporate strategies as well as appropriate business administration, the knowledge, experience and ability described in the schedule below are specifically important from the viewpoint of the aforementioned principles and business orientation of Santen. In addition to the life science business and global viewpoint, Santen will continuously place emphasis on fields such as ESG and service to society. Upon appointment of Directors and Corporate Auditors, Santen shall consistently ensure balance and diversity by appointing personnel from various backgrounds, including those with expert knowledge and experience, to allow them to provide advice and supervision of the management from a multifaceted point of view, and shall place importance on valuing individuals without any other distinctions such as gender, age, nationality, race or ethnic group. Moreover, Santen respects the balance between inside and Outside Directors to secure the objectiveness of discussions, and concurrently therewith, both Directors and Corporate Auditors have a majority of outside officers.

Directors and Corporate Auditors
(both incumbent an candidates)

Corporate managementLife science businessUnderstanding medical field and patientsGlobal leadershipFinance and accountingLegal affairs and risk controlESG and service to society
DirectorAkira KUROKAWA
Takeshi ITO
(Representative Director)
Kanoko OISHI
(Outside Director)
(Outside Director)
(Outside Director)
(Outside Director)
(Outside Director)*
Corporate AuditorHiroshi ISAKA
(Standing Corporate Auditor)
Masahiko Ikaga
(Outside Corporate Auditor)
Junichi Asatani
(Outside Corporate Auditor)
Yaeko Hodaka
(Outside Corporate Auditor)
  • Among skills respectively held, two to three skills (maximum three skills), which are specifically advantageous or those with strong relevance to the business of Santen, are described.
  • Australian nationality.

Evaluation of the Effectiveness of the Board of Directors

To enhance its performance, we decide to analyze and evaluates the effectiveness of the Board of Directors every year. The summary of the latest results of evaluation is as follows:

Board of Corporate Auditors

Santen has adopted a governance system using corporate auditors. Santen will continue to further heighten the effectiveness and efficiency of this auditing system in collaboration with internal audit divisions. The board of corporate auditors consists of four members, including outside auditors. Corporate auditors formulate auditing policies and plans as well as attend meetings of the Board of Directors and other important meetings. In addition, corporate auditors oversee the execution of duties by directors through auditing the operational and financial status of Santen’s headquarters, major operating sites, and subsidiaries.

Tax Policy